Tag: Covaxin Trials

Bharat Biotech's Business Development & International Advocacy Head, Dr Raches Ella, exuded confidence that vaccine for kids may get the license in the third quarter of this year.

Hyderabad: Bharat Biotech, which recently received approval to conduct Phase III human trials of India’s first indigenous coronavirus vaccine, Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in […]